Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michele Albert, M.D.

Concepts (63)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brachytherapy7200712230.490 Why?
Gastrointestinal Hemorrhage3200711160.350 Why?
Rectal Diseases220071430.330 Why?
Rectum420078920.260 Why?
Urethra120034050.190 Why?
Prostatic Neoplasms72007111220.170 Why?
Urinary Bladder1200311520.140 Why?
Carcinoma2200723300.130 Why?
Radiation Injuries1200311890.130 Why?
Sarcoma, Synovial120061530.060 Why?
Urinary Retention120051060.060 Why?
Vulvar Neoplasms120062630.060 Why?
Radiotherapy Dosage2200728980.050 Why?
Adenocarcinoma3200663460.050 Why?
Radiation Protection120054240.050 Why?
Salvage Therapy1200712640.050 Why?
Radiotherapy, Intensity-Modulated120068010.040 Why?
Radiometry120058130.040 Why?
Prostate-Specific Antigen2200724690.040 Why?
Surgical Flaps1200616710.040 Why?
Magnetic Resonance Imaging42007364260.040 Why?
Radiotherapy Planning, Computer-Assisted1200516610.030 Why?
Prostatectomy1200318240.030 Why?
Neoadjuvant Therapy1200328270.020 Why?
Neoplasm Recurrence, Local1200792810.020 Why?
Aged620071693080.020 Why?
Follow-Up Studies32007391070.020 Why?
Models, Biological1200594690.020 Why?
Middle Aged720072209170.020 Why?
Male Urogenital Diseases12007480.020 Why?
Risk Assessment22007239960.020 Why?
Mesna12006620.020 Why?
Ifosfamide120062320.020 Why?
Antineoplastic Combined Chemotherapy Protocols12006117420.020 Why?
Aged, 80 and over22007589830.020 Why?
Numerical Analysis, Computer-Assisted120051190.020 Why?
Body Burden120051580.010 Why?
Male720073608410.010 Why?
Life Tables120033640.010 Why?
Relative Biological Effectiveness120053120.010 Why?
Computer Systems120034700.010 Why?
Organ Specificity1200519680.010 Why?
Intraoperative Care120037670.010 Why?
Doxorubicin1200622240.010 Why?
Humans820077615780.010 Why?
Gastrointestinal Diseases1200712000.010 Why?
Chemotherapy, Adjuvant1200635140.010 Why?
Prospective Studies32007544230.010 Why?
Kaplan-Meier Estimate1200764840.010 Why?
Neoplasm Invasiveness1200335970.010 Why?
Combined Modality Therapy1200685280.010 Why?
Acute Disease1200572370.010 Why?
Disease-Free Survival1200368150.010 Why?
Radiography1200369650.010 Why?
Computer Simulation1200562410.010 Why?
Sensitivity and Specificity12005146650.010 Why?
Risk Factors22007742120.010 Why?
Proportional Hazards Models12003124630.010 Why?
Treatment Outcome22007646840.000 Why?
Reproducibility of Results12005200990.000 Why?
Time Factors12007399700.000 Why?
Retrospective Studies12003806460.000 Why?
Female120063926880.000 Why?
Albert's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (11)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.